Research Article
Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes
Table 4
Oncologic reconstruction details.
| | Total (n = 237) | Pre-recall (n = 162) | Post-recall (n = 75) | value |
| Breast cancer surgery | Nipple-sparing mastectomy | 144 (60.76) | 106 (65.43) | 38 (50.67) | 0.018 | Skin-sparing mastectomy | 71 (29.96) | 45 (27.78) | 26 (34.67) | | Simple mastectomy | 8 (3.38) | 2 (1.23) | 6 (8.00) | | Modified radical mastectomy | 8 (3.38) | 6 (3.70) | 2 (2.67) | | Radical mastectomy | 2 (0.84) | 0 (0.00) | 2 (2.67) | | Total mastectomy | 2 (0.84) | 2 (1.23) | 0 (0.00) | | Lumpectomy | 2 (0.84) | 1 (0.62) | 1 (1.33) | | Reconstruction timing | Immediate | 51 (21.52) | 28 (17.28) | 23 (30.67) | 0.045 | Delayed-immediate | 63 (26.58) | 48 (29.63) | 15 (20.00) | | Delayed | 123 (51.90) | 86 (53.09) | 37 (49.33) | |
|
|
Bold values indicate statistical significance.
|